CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Valneva SE

VALN
$507M
Small Cap
NASDAQBiological Products, (No Diagnostic Substances)🇺🇸EuropeSAINT-HERBLAIN713 employees

Drugs in Pipeline

5

Phase 3 Programs

3

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

VALN News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Drug Pipeline
Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in Valneva SE's drug pipeline?

CatalystAlert tracks 5 drug candidates in Valneva SE's (VALN) pipeline across Phase 3, Phase 2. Its lead program is VLA2001 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Valneva SE's next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for Valneva SE (VALN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track VALN biotech catalysts?

Add VALN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Valneva SE's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply